|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200055364 |
|
最近更新日期: Date of Last Refreshed on: |
2022-08-14 21:21:34 |
|
注册时间: Date of Registration: |
2022-01-08 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
双胎妊娠剖宫产PVI与超声下IVC-CI的相关性 |
|
Public title: |
Correlation between PVI of cesarean section in twin pregnancy and IVC-CI under ultrasound |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
双胎妊娠剖宫产PVI与超声下IVC-CI的相关性 |
|
Scientific title: |
Correlation between PVI of cesarean section in twin pregnancy and IVC-CI under ultrasound |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张卉颖 |
研究负责人: |
张卉颖 |
|
Applicant: |
Zhang Huiying |
Study leader: |
Zhang Huiying |
|
申请注册联系人电话: Applicant telephone: |
+86 13851690367 |
研究负责人电话:
Study leader's |
+86 13851690367 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
279763402@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
279763402@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省南京市莫愁路天妃巷123号南京市妇幼保健院麻醉科 |
研究负责人通讯地址: |
江苏省南京市莫愁路天妃巷123号南京市妇幼保健院麻醉科 |
|
Applicant address: |
123 Tianfei Lane, Mochou Road, Nanjing, Jiangsu |
Study leader's address: |
123 Tianfei Lane, Mochou Road, Nanjing, Jiangsu |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
南京市妇幼保健院 |
||
|
Applicant's institution: |
Nanjing Maternal and Child Health Hospital |
||
|
研究负责人所在单位: |
南京市妇幼保健院 |
||
|
Affiliation of the Leader: |
Nanjing Maternal and Child Health Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2021KY-108 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
南京市妇幼保健院医学伦理委员会 |
||
|
Name of the ethic committee: |
Nanjing Maternal and Child Health Hospital Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-01-18 00:00:00 | ||
|
伦理委员会联系人: |
陈婷 |
||
|
Contact Name of the ethic committee: |
Chen Ting |
||
|
伦理委员会联系地址: |
江苏省南京市秦淮区天妃巷123号 |
||
|
Contact Address of the ethic committee: |
123 Tianfei Lane, Qinhuai District, Nanjing, Jiangsu |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
南京市妇幼保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
Nanjing Maternal and Child Health Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省南京市莫愁路天妃巷123号南京市妇幼保健院麻醉科 |
||||||||||||||||||||||
|
Primary sponsor's address: |
123 Tianfei Lane, Mochou Road, Nanjing, Jiangsu |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自主研究 |
||||||||||||||||||||||
|
Source(s) of funding: |
Independent research |
||||||||||||||||||||||
|
研究疾病: |
双胎妊娠 |
||||||||||||||||||||||
|
Target disease: |
twin pregnancy |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
本研究项目拟应用无创脉搏变异指数(PVI)联合、超声测量下腔静脉塌陷指数(IVC-CI)探究其在双胎妊娠剖宫产应用的相关性、一致性。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this study is to explore the correlation and consistency of non-invasive pulse variation index (PVI) combined with ultrasonic measurement of inferior vena cava collapse index (IVC-CI) in cesarean section of twin pregnancy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
择期双胎妊娠剖宫产产妇,美国麻醉医师协会评分(American Society of Anesthesiologists,ASA)为I-II级,年龄18-45岁。 |
||||||||||||||||||||||
|
Inclusion criteria |
Women undergoing cesarean section with elective twin pregnancy were rated as I-II by the American Society of anesthesiologists(ASA), aged from 18 to 45 years old. |
||||||||||||||||||||||
|
排除标准: |
1、先行阴道试产的双胎妊娠产妇;2、心肺、肝肾功能不全产妇;3、有严重感染、脱水、电解质紊乱和休克产妇;4、剑突下、左手手指局部皮肤感染、溃疡产妇;5、超声耦合剂过敏史产妇;6、重度子痫前期、妊娠合并糖尿病、周围神经障碍产妇;7、严重脑损伤、意识模糊、呼吸抑制者;8、椎管内麻醉绝对禁忌症产妇;9、入组前3个月以内曾参加过其他临床试验的产妇及正在参加其他临床试验的产妇;10、根据试验负责医师判断,实施试验可能会使受试者危险性增加、或可能无法获得足够试验数据的产妇。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1, twin pregnant women with vaginal trial delivery; 2, pregnant women with cardiopulmonary, hepatorenal dysfunction; 3, pregnant women with severe infection, dehydration, electrolyte disturbance and shock; 4, skin infection and ulcers under xiphoid process and left fingers; 5, history of hypersensitivity to ultrasound coupling agent; 6, severe preeclampsia, pregnancy complicated with diabetes, peripheral nerve disorder; 7, severe brain injury, vague consciousness and respiratory inhibition. 8. Parturients with absolute contraindications of intraspinal anesthesia; 9. Parturients who have participated in other clinical trials and are participating in other clinical trials within 3 months before joining the group; 10. According to the judgment of the doctor in charge of the trial, the implementation of the trial may increase the risk of the subjects, or may not be able to obtain sufficient trial data. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-01 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-01-01 00:00:00 至 To 2022-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不涉及 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not involved |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
文章 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
papers |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF+EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF+EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |